Patents/Inventors

Markus Klemke

BremenDE1 patent

2 Patents

US122031372025
Use of ADIPOQ Gene Expression Level for Classification of a Subject in Risk Groups in the Prognosis or Diagnosis of Type II Diabetes Mellitus
LIPOZYT MARKER UG
0 cites
US120496692024
Use of the IL-6 Gene Expression Level for Classification of a Subject in Risk Groups in the Prognosis or Diagnosis of Type II Diabetes Mellitus
LIPOCYTE BIOMED GmbH
0 cites